NASDAQ:ALT • US02155H2004
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALTIMMUNE INC (ALT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-06 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-11-07 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-10-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-13 | UBS | Maintains | Buy -> Buy |
| 2025-08-13 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-10 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-06-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-02 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | William Blair | Initiate | Market Perform |
| 2025-02-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | Stifel | Initiate | Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | UBS | Initiate | Buy |
| 2024-08-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2024-06-25 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2024-06-21 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 426K 708.57% | 20K -95.31% | 41K 105.00% | 4.424K -89.21% | 33.462M 756,308.52% | 302.49M 803.98% | 479.55M 58.53% | 724.68M 51.12% | 1.054B 45.44% | 1.509B 43.17% | 1.956B 29.62% | |
| EBITDA YoY % growth | -83.033M 7.95% | -102.934M -23.97% | N/A 11.78% | -130.424M -43.63% | -152.616M -17.01% | -79.377M 47.99% | -9.635M 87.86% | 109.49M 1,236.39% | 160.52M 46.61% | 315.43M 96.51% | 525.66M 66.65% | |
| EBIT YoY % growth | -83.51M 4.82% | -103.172M -23.54% | -94.489M 8.42% | -131.671M -39.35% | -138.146M -4.92% | 176.44M 227.72% | 269.21M 52.58% | 426.61M 58.47% | 672.16M 57.56% | 1.058B 57.40% | 1.463B 38.28% | |
| Operating Margin | -19,603.29% | -515,860.00% | -230,460.98% | -2,976,418.72% | -412.84% | 58.33% | 56.14% | 58.87% | 63.77% | 70.11% | 74.80% | |
| EPS YoY % growth | -1.44 18.64% | -1.34 6.94% | -1.01 24.63% | -1.24 -23.08% | -1.11 10.49% | 3.03 372.01% | 4.05 33.70% | 6.08 50.33% | 20.19 231.88% | 22.99 13.86% | 25.66 11.64% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.27 -2.38% | -0.29 -5.77% | -0.33 -56.43% | -0.35 -30.02% | -0.35 -32.80% | -0.34 -20.25% | -0.34 -4.53% | -0.34 2.18% | -0.33 5.71% | -0.33 2.94% | -0.33 2.94% |
| Revenue Q2Q % growth | 838.3 -83.23% | 1.01K -79.80% | 1.01K -79.80% | -100.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -28.379M -30.26% | -31.247M -36.67% | -45.697M -119.98% | -31.31M -27.03% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -28.97M -32.80% | -32.844M -43.28% | -39.464M -89.20% | -41.193M -42.57% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
15 analysts have analysed ALT and the average price target is 18.67 USD. This implies a price increase of 381.08% is expected in the next year compared to the current price of 3.88.
ALTIMMUNE INC (ALT) will report earnings on 2026-05-11, before the market open.
The consensus EPS estimate for the next earnings of ALTIMMUNE INC (ALT) is -0.27 USD and the consensus revenue estimate is 838.3 USD.
The consensus rating for ALTIMMUNE INC (ALT) is 78.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.